Mandibular osteonecrosis and the use of bisphosphonate in an oncologic patient: case report
DOI:
https://doi.org/10.33448/rsd-v11i13.35621Keywords:
Osteonecrosis; Bisphosphonates; Dentistry; Oncology; Bioethics.Abstract
Clinical case report of a patient who remains under medical oncology care due to bilateral malignant neoplasm of the breast with bilateral bone and lung metastasis, who developed difficult-to-manage mandibular osteonecrosis related to prosthetic oral trauma and the use of injectable bisphosphonates. This study was carried out in the dentistry service of the Oncology Center of the Oswaldo Cruz University Hospital of the University of Pernambuco. It was possible to take care of, favor and monitor the self-resolving of mandibular bone necrosis for two years, providing oral comfort and the absence of infection, without interruption of hormonal antineoplastic treatment; regardless of the initially proposed peripheral osteotomy procedure to be performed under general anesthesia, it was refused by the patient and family. The autonomy of the patient was respected, and thus, the Standard Operating Protocol for Oral Care (POP-Oral), by Vidal, 2012, associated with antibiotic and analgesic therapy, for three months, and then remained only with POP-Oral and biweekly applications 0.2% chlorhexidine gel until spontaneous expulsion of necrotic bone and excellent healing occurred. Currently, the patient remains under follow-up, remaining without symptoms or any other oral alteration. It is concluded that the treatment of osteonecrosis of the jaws is of great complexity, and there is still no specific treatment, but it is possible to contain, avoid infections and stabilize the evolution of bone lesions, with individualized care, a multidisciplinary team and the exercise of bioethics, in medical-dental practice, as can be seen in this report.
References
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate - related osteonecrosis of the jaws. (2007). J. Oral Maxillofac. Surg., 65(3), 369–376.
Albrecht, J., Meves, A. & Bigby, M. (2005). Case reports and case series from Lancet had significant impact on medical literature. J Clin Epidemiol, 58, 1227- 1232.
American Dental Association Council on Scientific Affairs (2006). Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. Journal of the American Dental Association (1939), 137(8), 1144–1150.
Araújo, M. G. C. de, Macêdo, T. S. de, Branco, I. V. M. C., Melo, M. C. F. de, Souza, M. L. M. de, Frade, A. L., & Vidal, A. K. de L. (2019a). Assistência odontológica em ambiente hospitalar. In Silva Neto, B. R. (Org), Prevenção E Promoção de Saúde 5, 52–62. Atena.
Araújo, M. G. C. de, Melo, M. C. F. de, Souza, M. L. M. de, Branco, I. V. M. C., Macêdo, T. S. de, & Vidal, A. K. de L. (2019b). Osteonecrose dos maxilares associada aos bifosfanatos. In Silva Neto, B. R. (Org), Prevenção E Promoção de Saúde 6, 161–172. Atena.
Bacci, C., Cerrato, A., Bardhi, E., Frigo, A. C., Djaballah, S. A., & Sivolella, S. (2022). A retrospective study on the incidence of medication-related osteonecrosis of the jaws (MRONJ) associated with different preventive dental care modalities. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 30(2), 1723–1729. https://doi.org/10.1007/s00520-021-06587-x
Bagan, J.-V. ., Jimenez, Y., Hernandez, S., Murillo, J., Diaz, J.-M. ., Poveda, R., Carbonell, E., Sanchis, J.-M. ., Gavalda, C., & Scully, C. (2009). Osteonecrosis of the jaws by intravenous bisphosphonates and osteoradionecrosis: A comparative study. Medicina Oral Patología Oral Y Cirugia Bucal, e616–e619.
Barbosa, A. M & Hércules, A. J. (2020). Eficácia e segurança do denosumabe comparado aos bifosfonados orais para tratamento de osteoporose e prevenção de fraturas: revisão rápida de evidências. Revista Científica Escola Estadual Saúde Pública Goiás - "Cândido Santiago", 6(2).
Bardin, L. (2010). Análise de conteúdo (70ª ed.).
Brozoski, M. A., Traina, A. A., Deboni, M. C. Z., Marques, M. M., & Naclério-Homem, M. da G. (2012). Osteonecrose maxilar associada ao uso de bisfosfonatos. Revista Brasileira de Reumatologia, 52, 265–270.
Cardoso, M. de F. A., Novikoff, S., Tresso, A., Segreto, R. A., & Cervantes, O. (2005). Prevenção e controle das seqüelas bucais em pacientes irradiados por tumores de cabeça e pescoço. Radiologia Brasileira, 38(2), 107–115.
Dias, D. H. S., Teixeira, V. P., Ribeiro, R. A., Barbosa, J. de S., & Júnior, J. N. R. A. (2016). Osteonecrose associada ao uso de alendronato de sódio: relato de caso. Revista Higei@ - Revista Científica de Saúde, 1(1).
Dias, L. L. (2019). Osteorradionecrose dos maxilares: um estudo descritivo. Anais Dos Seminários de Iniciação Científica, 22.
Duque, M., Ribeiro, A., Burzlaff, J., Silveira, V., Tonietto, L., & Calcagnotto, T. (2018). Osteonecrose mandibular associada ao uso de bisfosfonatos tratada com plasma rico em fibrina leucocitária: relato de caso. Revista Da Faculdade De Odontologia - UPF, 22(3).
Ehrenstein, V., Heide-Jørgensen, U., Schiødt, M., Akre, O., Herlofson, B. B., Hansen, S., Larsson Wexell, C., Nørholt, S. E., Tretli, S., Kjellman, A., Glennane, A., Lowe, K. A., & Sørensen, H. T. (2021). Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator-mandated cohort postauthorization safety study in Denmark, Norway, and Sweden. Cancer, 127(21), 4050–4058. https://doi.org/10.1002/cncr.33802
Epstein, J. B., Emerton, S., Lunn, R., Le, N., & Wong, F. L. W. (1999). Pretreatment assessment and dental management of patients with nasopharyngeal carcinoma. Oral Oncology, 35(1), 33–39.
Estrela, C. (2018). Metodologia Científica: Ciência, Ensino, Pesquisa (3ª ed.). Editora Artes Médicas.
Fan, H., Kim, S., Cho, Y., Eo, M., Lee, S., & Woo, K. (2014). New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomaterials Research, 18(1), 13.
Ferreira, K. D. M., Corrêa, P. D., Balenzio, G. R., Pigatti, F. M., Ferreira, D. de C., & Tannure, P. N. (2019). Osteoradionecrosis in a Patient Submitted to Head and Neck Radiotherapy: A Case Report. International Journal of Odontostomatology, 13(4), 428–432.
Filgueira, S. L., Santos, V. L. C. dos, Lima, A. M. R. de, Escudeiro, E. P., Silva, J. R. da, & Moraes, S. L. C. de. (2019). Manifestações clínicas da osteonecrose induzida por medicamentos. Ciência Atual – Revista Científica Multidisciplinar Do Centro Universitário São José, 13(1).
Grant, B.-T., Amenedo, C., Freeman, K., & Kraut, R. A. (2008). Outcomes of Placing Dental Implants in Patients Taking Oral Bisphosphonates: A Review of 115 Cases. Journal of Oral and Maxillofacial Surgery, 66(2), 223–230.
Grimaldi, N., Sarmento, V., Provedel, L., Almeida, D. de, & Cunha, S. da. (2005). Conduta do cirurgião-dentista na prevenção e tratamento da osteorradionecrose: revisão de literatura. Revista Brasileira De Cancerologia, 51(4), 319–324.
Hourtoulle, M. B. C. (2019). Fisiopatologia da osteorradionecrose da mandíbula e as consequências na cavidade oral. [Dissertação de Mestrado, Instituto Universitário Egas Moniz].
Instituto Nacional de Câncer José Alencar Gomes da Silva. (2020). O que é radioterapia? Ministério da saúde. Disponível em: https://www.inca.gov.br/perguntas-frequentes/o-que-e-radioterapia.
Jacobson, A. S., Buchbinder, D., Hu, K., & Urken, M. L. (2010). Paradigm shifts in the management of osteoradionecrosis of the mandible. Oral Oncology, 46(11), 795–801.
Jardim, J. de F. (2019). Editorial - Osteonecrose dos maxilares relacionada a medicamentos. Revista Expressão Católica Saúde, 4(1), 3.
Jesus, A., Sousa Filho, F., Cardoso, J., Câncio, A., Simões, C., & de Farias, J. (2019). Tratamento cirúrgico para osteonecrose dos maxilares induzida por bisfosfonatos: relatos de casos. Revista Da Faculdade De Odontologia - UPF, 24(1), 22-30.
Jham, B. C., Reis, P. M., Miranda, E. L., Lopes, R. C., Carvalho, A. L., Scheper, M. A., & Freire, A. R. (2007). Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clinical Oral Investigations, 12(1), 19–24.
Jham, B. C., & Freire, A. R. da S. (2006). Complicações bucais da radioterapia em cabeça e pescoço. Revista Brasileira de Otorrinolaringologia, 72(5), 704–708.
Kuhnt, T., Stang, A., Wienke, A., Vordermark, D., Schweyen, R., & Hey, J. (2016). Potential risk factors for jaw osteoradionecrosis after radiotherapy for head and neck cancer. Radiation Oncology, 11(1).
Lacerda, J. dos P. (2019). Osteonecrosis of the maxilaries associated with use of biphosphonate. Brazilian Journal of Implantology and Health Sciences, 1(2), 18-24.
Lakatos, E. M. & Marconi, M. A. (2003). Fundamentos de metodologia científica (5ª ed.). Atlas.
Lima, K., Da Cunha Queiroz, E., Mayra, E., Sousa, L., Vilana, & Araújo, M. (2019). Os efeitos da pentoxifilina e do tocoferol na prevenção e no tratamento de osteonecrose e osteorradionecrose: uma revisão de literatura. Jornada Odontológica dos Acadêmicos da Católica, 5.
Manzano, B. R., Santaella, N. G., Oliveira, M. A., Rubira, C. M. F., & Santos, P. S. da S. (2019). Retrospective study of osteoradionecrosis in the jaws of patients with head and neck cancer. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 45(1), 21.
Marx, R. E. (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. Journal of Oral and Maxillofacial Surgery, 61(9), 1115–1117.
Mauceri, R., Coniglio, R., Abbinante, A., Carcieri, P., Tomassi, D., Panzarella, V., Di Fede, O., Bertoldo, F., Fusco, V., Bedogni, A., & Campisi, G. (2022). The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer, 30(8), 6429–6440. https://doi.org/10.1007/s00520-022-06940-8
Mcleod, N. M. H., Pratt, C. A., Mellor, T. K., & Brennan, P. A. (2012). Pentoxifylline and tocopherol in the management of patients with osteoradionecrosis, the Portsmouth experience. British Journal of Oral and Maxillofacial Surgery, 50(1), 41–44.
Monteiro, L., Barreira, E., & Medeiros, L. (2005). Osteorradionecrose dos maxilares. Rev Port Estomatol Cir Maxilofac, 46(1), 49-62.
Moraes, P. de C., thomaz, L. A., silva, M. B. F., Junqueira, J. L. C., & Teixeira, R. G. (2016). Successful in a conservative treatment of osteoradionecrosis of the jaw: a case report and review of literature. RGO - Revista Gaúcha de Odontologia, 64(2), 212–218.
Moura, M. E. R., Regis, J. M. G., Menezes, M. L. F., Roberto, I. D. M. N., & Araújo, V. M. A. (2020). Os benefícios da laserterapia na prevenção e no tratamento da osteonecrose dos maxilares – revisão de literatura. Encontro de Extensão, Docência E Iniciação Científica (EEDIC), 7(0).
Mussi, C. C.; Santos, R. S. R. (2019). Osteorradionecrose na Odontologia: revisão de literatura. [Trabalho de conclusão de curso, Universidade de Taubaté].
Nabil, S., & Samman, N. (2011). Incidence and prevention of osteoradionecrosis after dental extraction in irradiated patients: a systematic review. International Journal of Oral and Maxillofacial Surgery, 40(3), 229–243.
Niewald, M., Mang, K., Barbie, O., Fleckenstein, J., Holtmann, H., Spitzer, W. J., & Rübe, C. (2014). Dental status, dental treatment procedures and radiotherapy as risk factors for infected osteoradionecrosis (IORN) in patients with oral cancer – a comparison of two 10 years’ observation periods. SpringerPlus, 3(1).
Oh, H.-K., Chambers, M. S., Martin, J. W., Lim, H.-J., & Park, H.-J. (2009). Osteoradionecrosis of the Mandible: Treatment Outcomes and Factors Influencing the Progress of Osteoradionecrosis. Journal of Oral and Maxillofacial Surgery, 67(7), 1378–1386.
Oliveira, I. Q. R. (2018). Oxigenação Hiperbárica e a Osteonecrose por bisfosfonatos Revisão Sistemática. [Trabalho de Conclusão de Curso, Universidade Federal de Uberlândia].
Pereira, A. S., Shitsuka, D. M., Pereira, F. J. & Shitsuka, R. (2018). Metodologia da pesquisa científica. UFSM.
Santos, R., Dall’Magro, A. K., Giacobbo, J., Lauxen, J. R., & Dall’Magro, E. (2015). Osteorradionecrose em pacientes submetidos à radioterapia de cabeça e pescoço: relato de caso. RFO UPF, 20(2), 232–237.
Sousa, A. S., Almeida, V. P., Taira, J., Savedra, L. F., Rodrigues, I. V., & Giro, G. (2019). Protocolo de atendimento odontológico de pacientes em tratamento com bisfosfonatos. Revista Saúde - UNG-Ser, 12(1/2), 54.
Van Poznak, C. H., Unger, J. M., Darke, A. K., Moinpour, C., Bagramian, R. A., Schubert, M. M., Hansen, L. K., Floyd, J. D., Dakhil, S. R., Lew, D. L., Wade, J. L., 3rd, Fisch, M. J., Henry, N. L., Hershman, D. L., & Gralow, J. (2021). Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. JAMA oncology, 7(2), 246–254. https://doi.org/10.1001/jamaoncol.2020.6353
Vidal, A. K. L. (2009). Protocolo Operacional Padrão de Cuidados Buco-Dentais (POP- Oral) para indivíduos sob terapia antineoplásica. Adaptado das Rotinas Internas do INCA (serviço de Odontologia). Nota prévia (Original), 2012.
Vilela-Carvalho, L. N., Tuany-Duarte, N., Andrade-Figueiredo, M., & López-Ortega, K. (2018). Osteonecrose dos maxilares relacionada ao uso de medicações: Diagnóstico, tratamento e prevenção. CES Odontología, 31(2), 48–63. https://doi.org/10.21615/cesodon.31.2.5
Yin, R. K. (2015). Estudo de caso: planejamento e métodos. Porto Alegre: Bookman.
Zanata, A., Felin, G. C., De Bona, M. C., Sawazaki, R., & De Conto, F. (2014). Osteonecrose mandibular associada ao uso de bisfosfonato de sódio em paciente com mieloma múltiplo. Revista Portuguesa de Estomatologia, Medicina Dentária E Cirurgia Maxilofacial, 55(2), 115–120.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Fernanda Teles Pereira; Laís Azevedo Lins de Holanda; Nathalia Melo de Medeiros ; Cristiana de Lima Tavares; Emanuel Dias Oliveira e Silva; Aurora Karla de Lacerda Vidal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
